Other
Stock-Based Comp
Medtronic Stock-Based Comp decreased by 3.4% to $86.00M in Q2 2025 compared to the prior quarter. Year-over-year, this metric grew by 3.6%, from $83.00M to $86.00M. Over 4 years (FY 2021 to FY 2025), Stock-Based Comp shows an upward trend with a 5.7% CAGR.
Analysis
StatementIncome Statement
SectionOther
First reportedQ1 2014
Last reportedQ1 2026Aug 26, 2025
Metric ID:
other_share_based_compensationHistorical Data
18 periods
| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $69.00M | $69.00M | $130.00M | $88.00M | $72.00M | $62.00M | $157.00M | $61.00M | $75.00M | $73.00M | $169.00M | $61.00M | $90.00M | $83.00M | $185.00M | $72.00M | $89.00M | $86.00M |
| QoQ Change | — | +0.0% | +88.4% | -32.3% | -18.2% | -13.9% | +153.2% | -61.1% | +23.0% | -2.7% | +131.5% | -63.9% | +47.5% | -7.8% | +122.9% | -61.1% | +23.6% | -3.4% |
| YoY Change | — | — | — | — | +4.3% | -10.1% | +20.8% | -30.7% | +4.2% | +17.7% | +7.6% | +0.0% | +20.0% | +13.7% | +9.5% | +18.0% | -1.1% | +3.6% |
Range$61.00M – $185.00M
CAGR+5.3%
Avg YoY Growth+5.5%
Median YoY Growth+6.0%
Stock-Based Comp at Other Companies
Frequently Asked Questions
- What is Medtronic's stock-based comp?
- Medtronic (MDT) reported stock-based comp of $86.00M in Q2 2025.
- How has Medtronic's stock-based comp changed year-over-year?
- Medtronic's stock-based comp increased by 3.6% year-over-year, from $83.00M to $86.00M.
- What is the long-term trend for Medtronic's stock-based comp?
- Over 4 years (2021 to 2025), Medtronic's stock-based comp has grown at a 5.7% compound annual growth rate (CAGR), from $344.00M to $429.00M.